FDA
-
-
-
-
-
-
-
Bionomics to Host KOL Webinar on BNC210 and Social Anxiety Disorder
-
-
-
-
-
-
-
Bionomics Files Registration Statement for Proposed Initial Public Offering in the United States
-
-
-
-
-
-
-
Agilex Biolabs Congratulates Bionomics Limited on BNC210 PK Results
-
-
-
-
-
-
-
Further Data Analysis of Bionomics’ Phase 2 Post Traumatic Stress Disorder Trial Shows the Potential for Significant Patient Benefit When Drug Exposure Is Adequate
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

